Gilead Stock Is Up 4%. See Also: Who Is Developing Prophylactic Vaccines for Coronavirus and Nektar’s News That Moved the Stock Up Over 8%.

Gilead Stock Is UP
Gilead Sciences' (GILD) provided its antiviral experimental drug remdesivir to physicians for a small number of patients infected with the 2019 novel coronavirus (2019-nCoV) as a possible emergency savior . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.